Kansas City, KS- Two remarkable patient stories shed light on how advances in personalized medicine and multidisciplinary care are transforming cancer treatment at The University of Kansas Cancer Center.
Euri Solis, a lifelong non-smoker and dedicated marathon runner, was stunned to learn she had a rare form of non-small cell lung cancer, driven by an EGFR gene mutation.
Thanks to the cancer center’s precision medicine program, his care team, led by Dr. Larry Corum, used genomic testing, advanced imaging, and a once-daily targeted therapy pill to treat his cancer at the molecular level. Today, Euri is in remission and back to living the active life he feared he might lose.
Kerrie Mooneyham was diagnosed with triple-positive breast cancer—an aggressive form of the disease marked by estrogen, progesterone, and HER2 receptor overexpression.
After seeking a second opinion at KU Cancer Center, she received a coordinated, personalized treatment plan including chemotherapy, HER2-targeted therapy, and a preventive double mastectomy. The multidisciplinary approach ensured comprehensive.
